DIURIL is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, Inc. The primary component is Chlorothiazide.
| Product ID | 65649-311_5431439b-abd5-4bc3-9873-8510f1ab9938 |
| NDC | 65649-311 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DIURIL |
| Generic Name | Chlorothiazide |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 1962-02-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA011870 |
| Labeler Name | Salix Pharmaceuticals, Inc |
| Substance Name | CHLOROTHIAZIDE |
| Active Ingredient Strength | 250 mg/5mL |
| Pharm Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1962-02-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA011870 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1962-02-15 |
| Ingredient | Strength |
|---|---|
| CHLOROTHIAZIDE | 250 mg/5mL |
| SPL SET ID: | bd936e35-1af8-42da-bcc0-f22489d68574 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 65649-311 | DIURIL | CHLOROTHIAZIDE |
| 0143-1209 | Chlorothiazide | Chlorothiazide |
| 0143-1210 | Chlorothiazide | Chlorothiazide |
| 0378-0150 | Chlorothiazide | chlorothiazide |
| 0378-0162 | Chlorothiazide | chlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DIURIL 72051925 0676884 Live/Registered |
MERCK & CO., INC. 1958-05-19 |
![]() DIURIL 72029293 0660963 Dead/Expired |
MERCK & CO., INC. 1957-05-02 |